Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients

@article{Li2016ProteomicPF,
  title={Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients},
  author={Li Li and Jiangyu Zhang and Qingshan Deng and Jieming Li and Zhengfen Li and Yao Xiao and Shui-wang Hu and Tiantian Li and Qiuxiao Tan and Xiaofang Li and Bingshu Luo and Hui-qin Mo},
  journal={PLoS ONE},
  year={2016},
  volume={11}
}
Objectives To identify differential protein expression pattern associated with polycystic ovary syndrome (PCOS). Methods Twenty women were recruited for the study, ten with PCOS as a test group and ten without PCOS as a control group. Differential in-gel electrophoresis (DIGE) analysis and mass spectroscopy were employed to identify proteins that were differentially expressed between the PCOS and normal ovaries. The differentially expressed proteins were further validated by western blot (WB… 
View PDF
15 Citations
Background Citations
2

Tables from this paper

15 Citations

Genome-wide methylation profiling in granulosa lutein cells of women with polycystic ovary syndrome (PCOS)
S100‐A9 protein in exosomes derived from follicular fluid promotes inflammation via activation of NF‐κB pathway in polycystic ovary syndrome
TLDR
It is shown that follicular fluid exosomes contain S100 calcium‐binding protein A9 (S100‐A9) protein, which significantly enhanced inflammation and disrupted steroidogenesis via activation of nuclear factor kappa B (NF‐κB) signalling pathway.
Role of 14-3-3β protein on ovarian folliculogenesis, steroidogenesis and its correlation in the pathogenesis of PCOS in mice.
Expression of genes that regulate follicle development and maturation during ovarian stimulation in poor responders.
An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence
TLDR
This paper represents an international collaboration of paediatric endocrine and other societies aiming to improve worldwide care of adolescent girls with polycystic ovary syndrome (PCOS) under the International Consortium of Paediatric Endocrinology (ICPE).
Proteomics of reproduction: Prospects and perspectives.
Genetics of Polycystic Ovary Syndrome
Dynamic expression of PGRMC1 and SERBP1 in human endometrium: an implication in the human decidualization process.
Proteogenomic Analysis to Identify Missing Proteins from Haploid Cell Lines
TLDR
This study demonstrates that expression proteomics coupled to proteogenomic analysis can be employed to identify many annotated and unannotated missing proteins.
Metabolic Surgery on Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
TLDR
It is indicated that patients with PCOS are expected to benefit from metabolic surgery, and could help potentially improve their reproductive outcomes, and metabolic surgery could be a new viable option for the clinical treatment of PCOS.
...
...

References

SHOWING 1-10 OF 58 REFERENCES
Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome.
TLDR
A proteomic approach comprised two-dimensional gel electrophoresis (2DE) analysis and mass spectroscopy was used to identify proteins and examine expression patterns in three PCOS and normal ovaries, demonstrating complexity in the regulation of ovarian protein expression in human PCOS.
The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis.
TLDR
It is suggested that apolipoprotein A-I can be useful as a granulosa cell biomarker of PCOS patients and that downregulated ApoA-I may be related to the disturbed production of steroid hormones in PCos patients.
The Role of Heat Shock Protein 90B1 in Patients with Polycystic Ovary Syndrome
TLDR
A critical role is demonstrated for HSP90B1 in the proliferation and survival of ovarian cells, suggesting a critical role in the pathogenesis of PCOS, and novel altered gene expression in the ovarian tissues of patients with PCOS is identified.
Proteomic profiles in hyperandrogenic syndromes.
TLDR
Identification of the physiological function of these proteins could help to understand ethiopathogenetic mechanisms of hyperandrogenic syndromes and its complications.
Proteomic and metabolomic approaches to the study of polycystic ovary syndrome
Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms.
TLDR
A variety of prefractionation methods were used to investigate the protein/peptide signatures in patients with Polycystic Ovary Syndrome (PCOS), and four potential PCOS biomarkers were identified.
Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis.
TLDR
Menstrual irregularity is common in adolescence and does not relate to clinical or biochemical HA, and diagnostic criteria for PCOS which include ovarian volume and morphology may be of limited use in adolescence.
Evaluating the association between endometrial cancer and polycystic ovary syndrome.
TLDR
This study has shown that women with PCOS are more likely at increased risk of endometrial cancer, and more studies are required to clarify the exact molecular mechanisms, determine the best way of screening and preventing disease progression.
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
TLDR
Treatment of PCOS is focused on the goals of ameliorating hyperandrogenic symptoms, inducing ovulation and preventing cardiometabolic complications, and ruling out other hyper androgenic or oligo-ovulatory disorders.
Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.
TLDR
Women with PCOS had an elevated prevalence of IGT, DM2 and metabolic syndrome in both BMI and non-BMI-matched studies and further research is required.
...
...